Literature DB >> 1483493

Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.

M A van Baak1, J M Mooij, P M Schiffers.   

Abstract

The volumes of distribution of the beta-adrenoceptor blocking agents propranolol and atenolol, and the calcium antagonist verapamil, during exercise have been investigated. Changes in the plasma concentrations of atenolol and propranolol during exhaustive exercise at 70% of maximal aerobic power were compared after 1 week of oral treatment (propranolol 80 mg b.d. and atenolol 100 mg once daily) in 12 healthy volunteers. In a second study the effect of 10 min exercise at 50% of maximal aerobic power on steady state plasma concentrations of propranolol, atenolol and verapamil was compared in 7 healthy subjects. The drugs were administered by a continuous intravenous infusion. The plasma concentration of atenolol was not changed by exercise in either study, but the plasma concentrations of propranolol and verapamil were significantly increased in both studies. However, after correction for changes in plasma volume during exercise, the plasma propranolol concentration was not significantly elevated in the second study. From the results it is concluded that exercise led to a reduction in the volume of distribution of propranolol during prolonged exercise (25 min) at 70% Wmax, which was not clearly demonstrable during 10 min exercise at 50% Wmax. The volume of distribution of verapamil was reduced during 10 min exercise at 50% Wmax. No change in the volume of distribution of atenolol during exercise could be shown. The changes in the volumes of distribution of propranolol and verapamil during exercise may contribute to preventing an increase in the half-life of these drugs in patients performing prolonged physical exercise.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483493     DOI: 10.1007/bf02285100

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans.

Authors:  J Mooy; B Arends; J van Kemenade; R Boehm; K H Rahn; M van Baak
Journal:  J Cardiovasc Pharmacol       Date:  1986 Sep-Oct       Impact factor: 3.105

2.  Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs in rats.

Authors:  N Yata; T Toyoda; T Murakami; A Nishiura; Y Higashi
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

3.  Tissue atenolol levels following chronic beta-adrenoceptor blockade using oral atenolol in dogs.

Authors:  M K Davies; J McAinsh
Journal:  J Pharm Pharmacol       Date:  1986-04       Impact factor: 3.765

4.  Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response.

Authors:  M P Russell; J G Webb; T Walle; H B Daniell; P J Privitera; T E Gaffney
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

5.  Studies on the uptake and binding of propranolol by rat tissues.

Authors:  D W Schneck; J F Pritchard; A H Hayes
Journal:  J Pharmacol Exp Ther       Date:  1977-12       Impact factor: 4.030

6.  Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.

Authors:  B Lemmer; H Winkler; T Ohm; M Fink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

7.  Influence of physical exercise on the pharmacokinetics of propranolol.

Authors:  B G Arends; R O Böhm; J E van Kemenade; K H Rahn; M A van Baak
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Plasma protein binding of propranolol enantiomers as a major determinant of their stereoselective tissue distribution in rats.

Authors:  H Takahashi; H Ogata; S Kanno; H Takeuchi
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

9.  Physiological pharmacokinetics and pharmacodynamics of (+/-)-verapamil in female rats.

Authors:  E L Todd; D R Abernethy
Journal:  Biopharm Drug Dispos       Date:  1987 May-Jun       Impact factor: 1.627

10.  Lactate release in relation to tissue lactate in human skeletal muscle during exercise.

Authors:  L Jorfeldt; A Juhlin-Dannfelt; J Karlsson
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-03
View more
  2 in total

1.  Transdermal patch drug delivery interactions with exercise.

Authors:  Thomas L Lenz; Nicole Gillespie
Journal:  Sports Med       Date:  2011-03-01       Impact factor: 11.136

Review 2.  Potential interactions between exercise and drug therapy.

Authors:  Thomas L Lenz; Nancy J Lenz; Michele A Faulkner
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.